Cortagen

Cortagen is a synthetic peptide derived from a fragment of the ACTH (adrenocorticotropic hormone) molecule. It is designed to exert neuroprotective and nootropic effects, making it a subject of interest in the field of neurobiology. Cortagen has been studied for its potential to improve cognitive function, support brain health, and protect against neurodegenerative diseases. Its mechanisms are linked to enhancing neuronal survival, reducing inflammation, and promoting brain plasticity.

Category

Neuroprotective Bioregulator Peptide

Sequence

H-Ala-Glu-Asp-Pro-OH

Molecular Weight

Approximately 430.4 g/mol

Molecular Formula

C17H26N4O9

Half Life

Cortagen Has a Short Half-Life That's Not Widely Reported

Most Common Uses

Cortagen is primarily used in certain regions, such as Russia, for its neuroprotective and bioregulatory properties. Medical professionals employ it to support recovery from neurological conditions, including traumatic brain injuries, stroke, and neurodegenerative disorders. The peptide is believed to enhance cognitive function and promote neuronal repair, making it a candidate for treating memory impairments and cognitive decline associated with aging.

In clinical practice, Cortagen is also explored for its potential to improve mental clarity and focus in patients with neurological deficits. It is used in short treatment courses tailored to the patient’s needs. Its application remains limited to specific regions due to varying regulatory approvals, and ongoing research continues to investigate its broader therapeutic potential.

Mechanism of Action

Cortagen exerts its effects primarily through neuroprotective and neuromodulatory mechanisms in the central nervous system. It interacts with neuronal cells to promote repair and regeneration, particularly in the context of neurological damage from conditions like stroke or traumatic brain injury. The peptide enhances synaptic plasticity by modulating neurotransmitter activity, including the regulation of glutamate and gamma-aminobutyric acid (GABA), which supports balanced neuronal signaling.

Cortagen also stimulates the production of neurotrophic factors, fostering neuronal survival and growth. Its anti-inflammatory properties help reduce oxidative stress in brain tissue, creating a favorable environment for recovery. These combined actions contribute to improved cognitive function and neurological restoration, making Cortagen a valuable agent in regions where it is approved for clinical use.

Structure and Pharmacology

Cortagen is a synthetic tetrapeptide with the amino acid sequence H-Ala-Glu-Asp-Pro-OH (one-letter code: AEDP). Its molecular formula is C17H26N4O9, and it has a molecular weight of 430.4 g/mol. The peptide’s compact structure, consisting of alanine, glutamic acid, aspartic acid, and proline, contributes to its stability and ability to interact with neurological pathways. This simple yet specific sequence allows Cortagen to penetrate biological barriers effectively, enabling its therapeutic effects in the central nervous system. The design of Cortagen reflects its role as a bioregulatory peptide, tailored to support neuronal function and repair.

Pharmacologically, Cortagen exerts its effects through neuroprotective and neuromodulatory actions, primarily targeting the central nervous system. Administered via intramuscular or subcutaneous injection, it promotes neuronal repair by stimulating the production of neurotrophic factors, which support neuron survival and growth. The peptide enhances synaptic plasticity by regulating neurotransmitter activity, particularly glutamate and gamma-aminobutyric acid (GABA), fostering balanced neuronal signaling.

Cortagen also exhibits anti-inflammatory properties, reducing oxidative stress in brain tissue, which aids recovery from neurological conditions such as stroke or traumatic brain injury. Its short half-life, typical of small peptides, necessitates daily dosing in clinical settings, with treatment courses often spanning 5 to 10 days. The ability of Cortagen to cross the blood-brain barrier ensures direct interaction with cerebral tissues, supporting its use in improving cognitive function and neurological recovery.

Dosages

Cortagen is typically administered via intramuscular or subcutaneous injection. For adults, the standard dose ranges from 0.1 to 5 milligrams (mg) per day, depending on the neurological condition being treated, such as stroke, traumatic brain injury, or cognitive impairment. Treatment courses generally last up to 20 days, with daily injections, and may be repeated after a break of one to two months based on medical evaluation. In most cases the cycle is repeated 2 to 3 times per year as needed.

Before injection, the lyophilized powder should be dissolved in sterile water or saline, ensuring proper preparation for safe administration. Dosage regimens are tailored to the patient’s needs, with progress monitored to optimize therapeutic outcomes.

Warnings and Cautions

Cortagen requires careful administration to ensure safety. Patients with known allergies to Cortagen or its components should avoid its use, as hypersensitivity reactions, such as rash or swelling, may occur and require immediate medical attention. People with severe liver or kidney dysfunction need close monitoring, as the peptide’s metabolism and clearance may be altered, potentially leading to adverse effects. Pregnant or breastfeeding women should avoid using Cortagen as safety data in these populations are limited. In pediatric patients, where Cortagen is sometimes used for neurological conditions, precise weight-based dosing is necessary to avoid complications. Mild side effects, such as irritation at the injection site, may occur, but persistent or severe symptoms warrant medical evaluation. Patients should be carefully monitored during treatment to rule out any unexpected reactions, ensuring Cortagen is used safely and effectively.

Research & Clinical Trials

Epigenetic Regulation of Aged Heterochromatin by Cortagen

Cortagen for Brain Disorders in Ischemia

Cortagen’s Effect on Mouse Heart Gene Expression

Sourcing

USA

LIMITLESS LIFE NOOTROPICS aka Biotech

Use Discount Code: EP20

SCANTIFIX

Use Discount Code: Exploringpeptides

Canada

BIOSLAB

Use Discount Code: EP10

Europe

DNLABResearch

Use Discount Code: EP15

Australia

LVLUPHEALTH

References

[1] Lezhava, T., Monaselidze, J., Jokhadze, T. et al. Epigenetic Regulation of “Aged” Heterochromatin by Peptide Bioregulator Cortagen. Int J Pept Res Ther 21, 157–163 (2015). https://doi.org/10.1007/s10989-014-9443-7

[2] Zarubina, I. V., & Shabanov, P. D. (2011). Eksperimental'naia i klinicheskaia farmakologiia, 74(2), 8–15.

[3] Anisimov, S. V., Khavinson, V. K.h, & Anisimov, V. N. (2004). Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray. Neuro endocrinology letters, 25(1-2), 87–93.

Related articles

SLU-PP-915: Benefits, Research & Comparison with SLU-PP-332

Adalank vs Selank: Differences, Benefits and Effects

Adamax vs Semax: Comparison, Benefits, and Effects

Common Mistakes When Reconstituting Peptides

Peptides Vs Proteins: What’s The Difference?

What Are Peptides and How Do They Work?